MetLife Investment Management’s BlueLinx BXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Hold |
|
|||||
|
2025
Q1 | $368K | Sell |
|
|||||
|
2024
Q4 | $510K | Hold |
|
|||||
|
2024
Q3 | $526K | Hold |
|
|||||
|
2024
Q2 | $465K | Buy |
|
|||||
|
2024
Q1 | $594K | Hold |
|
|||||
|
2023
Q4 | $517K | Hold |
|
|||||
|
2023
Q3 | $374K | Hold |
|
|||||
|
2023
Q2 | $428K | Hold |
|
|||||
|
2023
Q1 | $310K | Buy |
|
|||||
|
2022
Q4 | $313K | Sell |
|
|||||
|
2022
Q3 | $309K | Sell |
|
|||||
|
2022
Q2 | $338K | Hold |
|
|||||
|
2022
Q1 | $364K | Buy |
|
|||||
|
2021
Q4 | $333K | Hold |
|
|||||
|
2021
Q3 | $170K | Hold |
|
|||||
|
2021
Q2 | $175K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $137K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $141K | Hold |
|
|||||
|
2018
Q2 | $168K | Buy |
|